Sonoma Pharmaceuticals Stock Price Prediction

SNOA Stock  USD 2.69  0.03  1.13%   
At this time, the relative strength index (RSI) of Sonoma Pharmaceuticals' share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Sonoma Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
The successful prediction of Sonoma Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Sonoma Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Sonoma Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.80)
EPS Estimate Current Year
(2.80)
EPS Estimate Next Year
(1.20)
Wall Street Target Price
19.5
EPS Estimate Current Quarter
(1.00)
Using Sonoma Pharmaceuticals hype-based prediction, you can estimate the value of Sonoma Pharmaceuticals from the perspective of Sonoma Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sonoma Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Sonoma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Sonoma Pharmaceuticals after-hype prediction price

    
  USD 2.7  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Sonoma Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.
Intrinsic
Valuation
LowRealHigh
2.076.8111.55
Details
Naive
Forecast
LowNextHigh
0.052.697.42
Details
1 Analysts
Consensus
LowTargetHigh
17.7519.5021.65
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.6-0.6-0.6
Details

Sonoma Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Sonoma Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sonoma Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sonoma Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Sonoma Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Sonoma Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sonoma Pharmaceuticals' historical news coverage. Sonoma Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.14 and 7.44, respectively. We have considered Sonoma Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.69
2.70
After-hype Price
7.44
Upside
Sonoma Pharmaceuticals is moderately volatile at this time. Analysis and calculation of next after-hype price of Sonoma Pharmaceuticals is based on 3 months time horizon.

Sonoma Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Sonoma Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sonoma Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sonoma Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.07 
4.70
 0.00  
 0.00  
8 Events / Month
0 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.69
2.70
0.00 
9,400  
Notes

Sonoma Pharmaceuticals Hype Timeline

Sonoma Pharmaceuticals is at this time traded for 2.69. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sonoma is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.07%. %. The volatility of related hype on Sonoma Pharmaceuticals is about 94000.0%, with the expected price after the next announcement by competition of 2.69. The company has price-to-book ratio of 0.67. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sonoma Pharmaceuticals recorded a loss per share of 0.99. The entity last dividend was issued on the 20th of June 2019. The firm had 1:20 split on the 30th of August 2024. Given the investment horizon of 90 days the next estimated press release will be in about 8 days.
Check out Sonoma Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.

Sonoma Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Sonoma Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Sonoma Pharmaceuticals' future price movements. Getting to know how Sonoma Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sonoma Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies 0.00 0 per month 1.12  0.05  2.81 (2.16) 5.70 
EQEquillium 0.00 0 per month 0.00 (0.05) 7.35 (8.24) 26.15 
ME23Andme Holding Co 0.00 0 per month 0.00 (0.09) 9.23 (9.09) 30.29 
DMACDiaMedica Therapeutics 0.00 0 per month 3.96  0.09  8.64 (5.65) 47.69 
VALNValneva SE ADR 0.05 2 per month 3.35 (0.01) 7.78 (6.16) 25.53 
VANIVivani Medical 0.00 0 per month 0.00 (0.04) 3.60 (4.07) 20.23 
DNLIDenali Therapeutics 0.00 0 per month 0.00 (0.06) 6.73 (6.79) 19.28 
DNTHDianthus Therapeutics 0.00 0 per month 0.00 (0.09) 7.64 (6.00) 23.93 
DOMHDominari Holdings 0.00 0 per month 4.89  0.15  13.64 (7.26) 61.90 
VCELVericel Corp Ord 0.00 0 per month 1.40  0.16  5.15 (2.31) 12.86 

Sonoma Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Sonoma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sonoma using various technical indicators. When you analyze Sonoma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sonoma Pharmaceuticals Predictive Indicators

The successful prediction of Sonoma Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sonoma Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sonoma Pharmaceuticals based on analysis of Sonoma Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sonoma Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sonoma Pharmaceuticals's related companies.
 2022 2023 2024 2025 (projected)
Payables Turnover10.4613.1611.8512.44
Days Of Inventory On Hand118.61124.21111.7964.47

Story Coverage note for Sonoma Pharmaceuticals

The number of cover stories for Sonoma Pharmaceuticals depends on current market conditions and Sonoma Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sonoma Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sonoma Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Sonoma Pharmaceuticals Short Properties

Sonoma Pharmaceuticals' future price predictability will typically decrease when Sonoma Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sonoma Pharmaceuticals often depends not only on the future outlook of the potential Sonoma Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sonoma Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding454.5 K
Cash And Short Term Investments3.1 M

Complementary Tools for Sonoma Stock analysis

When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals